Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,293 publicly listed stocks with a combined market cap of $2.10 Trillion. Acumen Pharmaceuticals Inc leads the sector with a market cap of $155.29 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$2.10 Trillion
Companies Listed
1,293
Largest Company
Acumen Pharmaceuticals Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 601 |
Acumen Pharmaceuticals Inc
NASDAQ:ABOS |
$155.29 Million | $155.29 Million | USA | $2.89 | +3.58% | -9.12% | 9.21 Million |
| 602 |
Saniona AB
ST:SANION |
$153.89 Million | Skr1.43 Billion | Sweden | Skr10.36 | +2.27% | -6.33% | 11.07 Million |
| 603 |
Immunic Inc
NASDAQ:IMUX |
$152.97 Million | $152.97 Million | USA | $11.23 | -1.66% | -21.14% | 5.51 Million |
| 604 |
Oramed Pharmaceuticals Inc
NASDAQ:ORMP |
$149.38 Million | $149.38 Million | USA | $4.62 | -1.07% | -7.78% | 5.24 Million |
| 605 |
KNOTUS Co.Ltd
KQ:278650 |
$148.84 Million | ₩219.62 Billion | Korea | ₩2600.00 | +14.04% | +8.11% | 2.23 Million |
| 606 |
Theratechnologies Inc.
TO:TH |
$148.68 Million | CA$205.53 Million | Canada | CA$4.47 | -4.89% | -1.76% | 333.19K |
| 607 |
Mycenax Biotech
TWO:4726 |
$147.60 Million | NT$4.69 Billion | Taiwan | NT$22.60 | -1.53% | -4.64% | 2.94 Million |
| 608 |
InflaRx N.V
F:IF0 |
$146.05 Million | €124.92 Million | Germany | €1.73 | -3.73% | -4.37% | 6.30K |
| 609 |
Molecular Partners AG
SW:MOLN |
$145.86 Million | CHF115.37 Million | Switzerland | CHF3.37 | +3.06% | +0.90% | 468.52K |
| 610 |
Mersana Therapeutics Inc
NASDAQ:MRSN |
$145.36 Million | $145.36 Million | USA | $29.08 | +0.14% | -0.07% | 2.50 Million |
| 611 |
Panion & BF Biotech Inc
TW:1760 |
$145.33 Million | NT$4.61 Billion | Taiwan | NT$53.80 | -0.19% | -4.61% | 2.71 Million |
| 612 |
Genovis AB (publ.)
ST:GENO |
$144.32 Million | Skr1.34 Billion | Sweden | Skr20.30 | +1.00% | -4.69% | 2.88 Million |
| 613 |
Oncolytics Biotech Inc
TO:ONC |
$142.51 Million | CA$197.01 Million | Canada | CA$14.90 | +0.00% | +0.00% | 280.00 |
| 614 |
PROQR THERAPEUTICS EO-04
F:0PQ |
$142.34 Million | €121.75 Million | Germany | €1.58 | -1.25% | -8.88% | 180.00 |
| 615 |
Whitehawk Therapeutics, Inc.
NASDAQ:WHWK |
$141.39 Million | $141.39 Million | USA | $4.09 | +0.49% | -11.09% | 6.51 Million |
| 616 |
TIZIANA LIFE SCIENCES LTD
F:0RP |
$141.34 Million | €120.90 Million | Germany | €0.95 | -2.56% | -9.52% | 68.00K |
| 617 |
Neumora Therapeutics, Inc.
NASDAQ:NMRA |
$141.27 Million | $141.27 Million | USA | $0.83 | -16.82% | -36.54% | 18.60 Million |
| 618 |
Prelude Therapeutics Inc
NASDAQ:PRLD |
$140.19 Million | $140.19 Million | USA | $4.52 | -1.53% | -17.22% | 13.13 Million |
| 619 |
LENZ Therapeutics Inc
NASDAQ:LENZ |
$140.15 Million | $140.15 Million | USA | $4.47 | -1.11% | -22.93% | 17.24 Million |
| 620 |
SANIONA AB (PUBL)
F:30S |
$140.07 Million | €119.81 Million | Germany | €0.87 | -5.40% | -15.81% | 0.00 |
| 621 |
Hyloris Developmentsen Sa
BR:HYL |
$138.80 Million | €118.72 Million | Belgium | €4.24 | +0.95% | -3.64% | 38.74K |
| 622 |
Solux Co. Ltd
KQ:290690 |
$136.90 Million | ₩202.02 Billion | Korea | ₩4095.00 | -0.36% | -2.62% | 8.63 Million |
| 623 |
Kangstem Biotech Co. Ltd
KQ:217730 |
$136.72 Million | ₩201.75 Billion | Korea | ₩2145.00 | +1.66% | -3.60% | 8.02 Million |
| 624 |
Tenaya Therapeutics Inc
NASDAQ:TNYA |
$136.66 Million | $136.66 Million | USA | $0.67 | -3.23% | -1.86% | 44.30 Million |
| 625 |
Orthocell Ltd
AU:OCC |
$136.30 Million | AU$192.63 Million | Australia | AU$0.71 | -1.39% | -2.74% | 5.16 Million |
| 626 |
Caribou Biosciences Inc
NASDAQ:CRBU |
$136.15 Million | $136.15 Million | USA | $1.27 | -1.55% | -19.11% | 27.51 Million |
| 627 |
Heidelberg Pharma AG
F:HPHA |
$135.65 Million | €116.03 Million | Germany | €2.48 | +1.22% | +2.06% | 4.40K |
| 628 |
Vytrus Biotech S.A.
MC:VYT |
$135.30 Million | €115.73 Million | Spain | €16.50 | +0.00% | -2.65% | 71.06K |
| 629 |
Spruce Biosciences, Inc. Common Stock
NASDAQ:SPRB |
$135.28 Million | $135.28 Million | USA | $55.17 | -2.96% | -4.77% | 2.14 Million |
| 630 |
Corbus Pharmaceuticals Holding
NASDAQ:CRBP |
$133.84 Million | $133.84 Million | USA | $6.92 | -14.36% | -37.55% | 27.44 Million |
| 631 |
Innate Pharma
NASDAQ:IPHA |
$133.24 Million | $133.24 Million | USA | $1.86 | +0.54% | -10.58% | 1.39 Million |
| 632 |
MOLECULAR PARTNERS ADS/1
F:6ML0 |
$133.19 Million | €113.92 Million | Germany | €3.54 | -3.80% | +0.00% | 17.40K |
| 633 |
Fate Therapeutics Inc
NASDAQ:FATE |
$131.50 Million | $131.50 Million | USA | $2.35 | +0.43% | -5.24% | 30.87 Million |
| 634 |
Nykode Therapeutics ASA
OL:NYKD |
$130.92 Million | Nkr1.24 Billion | Norway | Nkr3.81 | -1.30% | -5.34% | 97.67 Million |
| 635 |
Tharimmune Inc.
NASDAQ:THAR |
$130.84 Million | $130.84 Million | USA | $3.31 | -5.70% | +0.00% | 15.04 Million |
| 636 |
Unicycive Therapeutics Inc
NASDAQ:UNCY |
$129.02 Million | $129.02 Million | USA | $4.71 | -8.54% | -8.72% | 19.72 Million |
| 637 |
VYTRUS BIOTECH EO -01
F:V5P |
$128.53 Million | €109.94 Million | Germany | €15.95 | +0.00% | -2.45% | 26.00 |
| 638 |
Actinogen Medical Ltd
AU:ACW |
$128.19 Million | AU$181.17 Million | Australia | AU$0.06 | -5.00% | -3.39% | 115.44 Million |
| 639 |
TuHURA Biosciences Inc
NASDAQ:HURA |
$128.09 Million | $128.09 Million | USA | $2.03 | -0.98% | -5.14% | 5.87 Million |
| 640 |
Alpha Cognition Inc
NASDAQ:ACOG |
$127.19 Million | $127.19 Million | USA | $8.80 | +1.03% | -7.56% | 3.92 Million |
| 641 |
Nyrada Inc
AU:NYR |
$125.66 Million | AU$177.59 Million | Australia | AU$0.73 | +7.41% | -2.03% | 6.73 Million |
| 642 |
Equillium Inc
NASDAQ:EQ |
$124.83 Million | $124.83 Million | USA | $2.05 | -2.15% | -7.24% | 9.96 Million |
| 643 |
enGene Holdings Inc. Common Stock
NASDAQ:ENGN |
$123.98 Million | $123.98 Million | USA | $1.89 | +1.07% | +3.85% | 17.68 Million |
| 644 |
vTv Therapeutics Inc
NASDAQ:VTVT |
$123.83 Million | $123.83 Million | USA | $31.44 | -1.66% | -5.87% | 1.33 Million |
| 645 |
Humacyte Inc
NASDAQ:HUMA |
$122.47 Million | $122.47 Million | USA | $0.55 | -1.68% | -8.83% | 216.72 Million |
| 646 |
Sensorion SA
PA:ALSEN |
$122.13 Million | €104.47 Million | France | €10.47 | +4712.87% | +4087.20% | 15.75 Million |
| 647 |
Cibus Global LLC
NASDAQ:CBUS |
$120.76 Million | $120.76 Million | USA | $1.58 | +6.04% | -0.63% | 2.90 Million |
| 648 |
Digital Aria Co Ltd
KQ:115450 |
$119.24 Million | ₩175.96 Billion | Korea | ₩1996.00 | +2.41% | -4.04% | 5.21 Million |
| 649 |
Inhibikase Therapeutics Inc
NASDAQ:IKT |
$119.23 Million | $119.23 Million | USA | $2.31 | -3.35% | -7.60% | 9.42 Million |
| 650 |
Conexeu Sciences Inc. Common Stock
NASDAQ:CNXU |
$119.07 Million | $119.07 Million | USA | $4.45 | -11.00% | -10.46% | 6.24 Million |
| 651 |
OnKure Therapeutics, Inc.
NASDAQ:OKUR |
$118.65 Million | $118.65 Million | USA | $2.93 | -2.33% | -18.16% | 3.79 Million |
| 652 |
Vaxart Inc
NASDAQ:VXRT |
$118.57 Million | $118.57 Million | USA | $0.49 | +0.00% | +0.00% | 4.26 Million |
| 653 |
Cellectis SA
NASDAQ:CLLS |
$117.08 Million | $117.08 Million | USA | $1.61 | -12.02% | -50.31% | 2.37 Million |
| 654 |
INNATE PHARMA SP.ADR/1
F:IDDA |
$116.15 Million | €99.35 Million | Germany | €1.06 | -9.40% | -26.90% | 6.23K |
| 655 |
Leap Therapeutics Inc
NASDAQ:LPTX |
$116.14 Million | $116.14 Million | USA | $2.05 | +368.57% | +391.14% | 817.45 Million |
| 656 |
Innate Pharma
PA:IPH |
$115.22 Million | €98.56 Million | France | €1.55 | -1.28% | -8.94% | 13.86 Million |
| 657 |
Genovate Biotechnology Co Ltd
TWO:4130 |
$115.03 Million | NT$3.65 Billion | Taiwan | NT$26.70 | -0.37% | -5.15% | 4.08 Million |
| 658 |
Cellectis
PA:ALCLS |
$114.74 Million | €98.14 Million | France | €1.35 | -10.30% | -53.61% | 7.18 Million |
| 659 |
Repare Therapeutics Inc
NASDAQ:RPTX |
$114.24 Million | $114.24 Million | USA | $2.65 | +0.76% | +2.71% | 37.69 Million |
| 660 |
GREEN CROSS WellBeing Corporation
KQ:234690 |
$113.40 Million | ₩167.34 Billion | Korea | ₩9430.00 | -0.84% | -7.09% | 16.31 Million |
| 661 |
Scisparc Ltd
NASDAQ:SPRC |
$113.29 Million | $113.29 Million | USA | $4.91 | -3.35% | -16.07% | 1.56 Million |
| 662 |
Tiziana Life Sciences Ltd
NASDAQ:TLSA |
$113.26 Million | $113.26 Million | USA | $0.89 | -7.29% | -4.30% | 20.56 Million |
| 663 |
Codexis Inc
NASDAQ:CDXS |
$112.91 Million | $112.91 Million | USA | $1.40 | -5.41% | -4.11% | 23.15 Million |
| 664 |
Black Diamond Therapeutics Inc
NASDAQ:BDTX |
$112.88 Million | $112.88 Million | USA | $1.97 | -2.96% | -7.08% | 12.72 Million |
| 665 |
Nautilus Biotechnology Inc
NASDAQ:NAUT |
$112.55 Million | $112.55 Million | USA | $0.89 | -1.68% | -1.54% | 20.86 Million |
| 666 |
CANBRIDGE PHARM.DL-00001
F:MF1 |
$111.14 Million | €95.07 Million | Germany | €0.19 | +0.00% | +21.57% | 0.00 |
| 667 |
Vivani Medical Inc.
NASDAQ:VANI |
$110.95 Million | $110.95 Million | USA | $1.23 | -2.38% | -17.45% | 5.59 Million |
| 668 |
Genelux Corporation Common Stock
NASDAQ:GNLX |
$110.76 Million | $110.76 Million | USA | $2.47 | -2.76% | +1.23% | 7.84 Million |
| 669 |
Arcticzymes Technologies ASA
OL:AZT |
$110.71 Million | Nkr1.05 Billion | Norway | Nkr20.60 | +0.00% | -2.37% | 1.01 Million |
| 670 |
SynAct Pharma AB
ST:SYNACT |
$110.28 Million | Skr1.02 Billion | Sweden | Skr18.30 | -1.72% | -4.98% | 4.74 Million |
| 671 |
Captor Therapeutics S.A.
WAR:CTX |
$109.92 Million | zł399.38 Million | Poland | zł72.50 | +0.28% | +2.84% | 61.01K |
| 672 |
NIBEC Co. Ltd
KQ:138610 |
$109.62 Million | ₩161.76 Billion | Korea | ₩14230.00 | -0.63% | -6.07% | 3.23 Million |
| 673 |
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD |
$109.30 Million | $109.30 Million | USA | $5.02 | -9.55% | -6.69% | 3.41 Million |
| 674 |
Coya Therapeutics, Inc. Common Stock
NASDAQ:COYA |
$109.08 Million | $109.08 Million | USA | $4.65 | +0.22% | -2.31% | 2.51 Million |
| 675 |
Alterity Therapeutics Ltd
AU:ATH |
$108.75 Million | AU$153.70 Million | Australia | AU$0.43 | -5.56% | -14.14% | 9.23 Million |
| 676 |
OBI Pharma
TWO:4174 |
$107.78 Million | NT$3.42 Billion | Taiwan | NT$26.00 | +3.59% | +4.21% | 7.98 Million |
| 677 |
Gossamer Bio Inc
NASDAQ:GOSS |
$106.47 Million | $106.47 Million | USA | $10.38 | -2.99% | +5831.43% | 417.41 Million |
| 678 |
Ryvu Therapeutics SA
WAR:RVU |
$106.26 Million | zł386.11 Million | Poland | zł16.70 | -1.65% | -3.58% | 866.50K |
| 679 |
Biosolution Co.Ltd
KQ:086820 |
$105.48 Million | ₩155.64 Billion | Korea | ₩6450.00 | +0.78% | +0.78% | 2.24 Million |
| 680 |
Seer Inc
NASDAQ:SEER |
$105.21 Million | $105.21 Million | USA | $1.90 | -0.52% | -2.56% | 4.64 Million |
| 681 |
Hillevax Inc
NASDAQ:HLVX |
$104.76 Million | $104.76 Million | USA | $2.09 | +0.00% | +0.00% | 0.00 |
| 682 |
SYN-Tech Chem & Pharm Co Ltd
TWO:1777 |
$103.12 Million | NT$3.27 Billion | Taiwan | NT$73.40 | +0.27% | -2.52% | 1.05 Million |
| 683 |
Polaryx Therapeutics, Inc. Common Stock
NASDAQ:PLYX |
$101.94 Million | $101.94 Million | USA | $2.05 | +1.24% | +2.25% | 2.10 Million |
| 684 |
MEI Pharma Inc
NASDAQ:MEIP |
$100.81 Million | $100.81 Million | USA | $3.07 | +0.00% | +0.00% | 4.03 Million |
| 685 |
Dimerix Ltd
AU:DXB |
$99.83 Million | AU$141.09 Million | Australia | AU$0.24 | -2.08% | -16.07% | 26.60 Million |
| 686 |
STARPHARMA HLDG.SP.ADR/10
F:PQ6A |
$99.13 Million | €84.79 Million | Germany | €4.40 | -3.51% | +20.22% | 0.00 |
| 687 |
AlzeCure Pharma
ST:ALZCUR |
$98.93 Million | Skr919.32 Million | Sweden | Skr8.00 | -2.20% | -4.53% | 12.01 Million |
| 688 |
Sagittarius Life Science
TWO:3205 |
$98.64 Million | NT$3.13 Billion | Taiwan | NT$46.35 | -0.11% | -0.96% | 725.67K |
| 689 |
Adverum Biotechnologies Inc
NASDAQ:ADVM |
$96.26 Million | $96.26 Million | USA | $4.36 | +0.00% | +3.81% | 11.22 Million |
| 690 |
Immunoprecise Antibodies Ltd
NASDAQ:IPA |
$95.54 Million | $95.54 Million | USA | $2.07 | +0.00% | +0.00% | 1.97 Million |
| 691 |
Anixa Biosciences Inc
NASDAQ:ANIX |
$95.26 Million | $95.26 Million | USA | $2.80 | +1.45% | -10.54% | 7.18 Million |
| 692 |
Apex Biotechnology Corp
TW:1733 |
$94.15 Million | NT$2.99 Billion | Taiwan | NT$29.90 | -1.48% | -5.68% | 3.06 Million |
| 693 |
Infant Bacterial Therapeutics AB (publ)
ST:IBT-B |
$92.46 Million | Skr859.20 Million | Sweden | Skr66.00 | +1.54% | +2.96% | 259.45K |
| 694 |
Rani Therapeutics Holdings Inc
NASDAQ:RANI |
$92.33 Million | $92.33 Million | USA | $0.82 | -1.71% | -5.03% | 15.35 Million |
| 695 |
Paradigm Biopharmaceuticals Ltd
AU:PAR |
$91.95 Million | AU$129.96 Million | Australia | AU$0.25 | +4.17% | -9.09% | 83.68 Million |
| 696 |
Cognition Therapeutics Inc
NASDAQ:CGTX |
$91.36 Million | $91.36 Million | USA | $1.04 | +2.48% | +0.49% | 9.37 Million |
| 697 |
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS |
$89.94 Million | $89.94 Million | USA | $0.57 | -7.62% | -18.94% | 34.48 Million |
| 698 |
Synergy Innovation Co. Ltd
KQ:048870 |
$89.86 Million | ₩132.60 Billion | Korea | ₩1505.00 | -1.12% | -4.57% | 5.84 Million |
| 699 |
BIOCELTIX S.A. ZY -10
F:XI3 |
$89.73 Million | €76.75 Million | Germany | €20.40 | +6.36% | +10.39% | 0.00 |
| 700 |
Cardiff Oncology Inc
NASDAQ:CRDF |
$89.56 Million | $89.56 Million | USA | $1.31 | +8.26% | +23.58% | 18.09 Million |
| 701 |
Eastwood Bio-Medical Canada Inc
V:EBM |
$89.55 Million | CA$123.80 Million | Canada | CA$1.80 | +0.00% | -5.26% | 354.57K |
| 702 |
Bioton S.A.
WAR:BIO |
$87.43 Million | zł317.70 Million | Poland | zł3.70 | -0.27% | -2.12% | 643.76K |
| 703 |
Terns Pharmaceuticals Inc
NASDAQ:TERN |
$87.01 Million | $87.01 Million | USA | $0.80 | +0.00% | +63.27% | 80.93 Million |
| 704 |
ImmuCell Corporation
NASDAQ:ICCC |
$87.01 Million | $87.01 Million | USA | $9.58 | -1.34% | -3.23% | 667.82K |
| 705 |
Pyxis Oncology Inc
NASDAQ:PYXS |
$86.55 Million | $86.55 Million | USA | $3.33 | -2.92% | -14.40% | 23.22 Million |
| 706 |
Genexine Inc
KQ:095700 |
$86.45 Million | ₩127.57 Billion | Korea | ₩2805.00 | +0.54% | -8.18% | 18.40 Million |
| 707 |
Biomea Fusion Inc
NASDAQ:BMEA |
$86.04 Million | $86.04 Million | USA | $1.80 | +1.12% | -11.33% | 48.44 Million |
| 708 |
NeOnc Technologies Holdings, Inc. Common Stock
NASDAQ:NTHI |
$85.85 Million | $85.85 Million | USA | $3.31 | -12.43% | -34.19% | 6.57 Million |
| 709 |
Rallybio Corp
NASDAQ:RLYB |
$85.82 Million | $85.82 Million | USA | $17.22 | +4.30% | +1.74% | 327.66K |
| 710 |
Pelthos Therapeutics Inc.
NYSE MKT:PTHS |
$85.55 Million | $85.55 Million | USA | $26.66 | -1.62% | -3.72% | 583.37K |
| 711 |
Intech Biopharm Ltd
TWO:6461 |
$85.51 Million | NT$2.71 Billion | Taiwan | NT$24.60 | -3.53% | -8.61% | 2.82 Million |
| 712 |
Neuraxis, Inc.
NYSE MKT:NRXS |
$84.91 Million | $84.91 Million | USA | $7.38 | -0.67% | -11.62% | 4.63 Million |
| 713 |
Immutep Ltd ADR
NASDAQ:IMMP |
$84.03 Million | $84.03 Million | USA | $0.57 | -3.65% | +4.94% | 807.12 Million |
| 714 |
Adocia
PA:ADOC |
$83.81 Million | €71.69 Million | France | €3.66 | +3.33% | -7.38% | 1.99 Million |
| 715 |
Island Pharmaceuticals Ltd
AU:ILA |
$83.76 Million | AU$118.38 Million | Australia | AU$0.44 | +2.33% | -2.22% | 3.55 Million |
| 716 |
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ:ARTV |
$82.80 Million | $82.80 Million | USA | $8.91 | -12.13% | -20.38% | 7.00 Million |
| 717 |
Aldeyra The
NASDAQ:ALDX |
$82.65 Million | $82.65 Million | USA | $1.37 | -6.16% | -7.43% | 17.80 Million |
| 718 |
Chunghwa Chemical Synthesis & Biotech Co Ltd
TW:1762 |
$81.18 Million | NT$2.58 Billion | Taiwan | NT$33.50 | +0.00% | -4.29% | 2.59 Million |
| 719 |
MediciNova Inc
NASDAQ:MNOV |
$80.60 Million | $80.60 Million | USA | $2.02 | +8.02% | +23.93% | 1.48 Million |
| 720 |
Xlife Sciences AG
SW:XLS |
$79.88 Million | CHF63.18 Million | Switzerland | CHF13.45 | -0.37% | +6.75% | 91.94K |
| 721 |
Inovio Pharmaceuticals Inc
NASDAQ:INO |
$79.70 Million | $79.70 Million | USA | $1.16 | -1.69% | -18.88% | 106.80 Million |
| 722 |
Adicet Bio Inc
NASDAQ:ACET |
$79.62 Million | $79.62 Million | USA | $8.51 | -12.32% | -11.31% | 2.63 Million |
| 723 |
Fortress Biotech Inc
NASDAQ:FBIO |
$79.39 Million | $79.39 Million | USA | $2.49 | -1.58% | -8.46% | 11.16 Million |
| 724 |
VIVANI MED.INC. NEW O.N.
F:U5P |
$79.34 Million | €67.86 Million | Germany | €1.01 | -1.94% | -17.21% | 0.00 |
| 725 |
Milestone Pharmaceuticals Inc
NASDAQ:MIST |
$79.01 Million | $79.01 Million | USA | $0.93 | -2.29% | -22.69% | 44.84 Million |
| 726 |
Nanoform Finland Plc
HE:NANOFH |
$78.90 Million | €67.49 Million | Finland | €0.86 | +1.17% | -4.42% | 1.68 Million |
| 727 |
Verrica Pharmaceuticals Inc
NASDAQ:VRCA |
$78.68 Million | $78.68 Million | USA | $4.58 | -4.18% | -13.58% | 2.38 Million |
| 728 |
PolyPid
NASDAQ:PYPD |
$77.73 Million | $77.73 Million | USA | $5.16 | -3.19% | -4.27% | 2.94 Million |
| 729 |
Aerovate Therapeutics Inc
NASDAQ:AVTE |
$77.68 Million | $77.68 Million | USA | $2.68 | +0.00% | +0.00% | 1.03 Million |
| 730 |
MAIA Biotechnology Inc.
NYSE MKT:MAIA |
$77.66 Million | $77.66 Million | USA | $1.28 | +0.00% | -5.88% | 12.98 Million |
| 731 |
RenovoRx Inc
NASDAQ:RNXT |
$77.62 Million | $77.62 Million | USA | $1.72 | +1.78% | -28.03% | 32.79 Million |
| 732 |
iBio, Inc. Common Stock
NASDAQ:IBIO |
$76.53 Million | $76.53 Million | USA | $1.19 | -0.83% | -9.16% | 15.00 Million |
| 733 |
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELO |
$76.34 Million | $76.34 Million | USA | $1.17 | +0.00% | +0.86% | 1.22 Million |
| 734 |
Helix BioPharma Corp.
TO:HBP |
$76.25 Million | CA$105.40 Million | Canada | CA$1.38 | -1.43% | -23.33% | 78.07K |
| 735 |
Kalaris Therapeutics, Inc.
NASDAQ:KLRS |
$76.14 Million | $76.14 Million | USA | $3.20 | -3.03% | -17.95% | 1.35 Million |
| 736 |
GlycoNex
TWO:4168 |
$75.34 Million | NT$2.39 Billion | Taiwan | NT$21.60 | -0.92% | -2.48% | 1.91 Million |
| 737 |
Brii Biosciences Limited
F:7SS |
$74.20 Million | €63.46 Million | Germany | €0.09 | -1.68% | -1.68% | 0.00 |
| 738 |
Connect Biopharma Holdings Ltd
NASDAQ:CNTB |
$73.67 Million | $73.67 Million | USA | $1.17 | -32.17% | -36.41% | 35.42 Million |
| 739 |
ORIENTBIO Inc.
KO:002630 |
$73.37 Million | ₩108.27 Billion | Korea | ₩913.00 | +8.69% | -1.30% | 9.47 Million |
| 740 |
Eyenovia Inc
NASDAQ:EYEN |
$73.30 Million | $73.30 Million | USA | $14.36 | +0.00% | +0.00% | 1.32 Million |
| 741 |
Gain Therapeutics Inc
NASDAQ:GANX |
$72.94 Million | $72.94 Million | USA | $1.71 | -1.72% | -5.00% | 9.75 Million |
| 742 |
Pmv Pharmaceuticals Inc
NASDAQ:PMVP |
$72.70 Million | $72.70 Million | USA | $1.36 | -6.85% | +5.43% | 16.47 Million |
| 743 |
Novogenia AG
XETRA:7V0 |
$72.00 Million | €61.59 Million | Germany | €6.90 | +6.15% | -6.76% | 46.26K |
| 744 |
Shanghai Haohai Biological Technology Co. Ltd
F:5HB |
$71.16 Million | €60.87 Million | Germany | €1.75 | -1.13% | -2.23% | 0.00 |
| 745 |
Nutriband Inc
NASDAQ:NTRB |
$70.50 Million | $70.50 Million | USA | $6.82 | -1.52% | +14.24% | 1.35 Million |
| 746 |
OSE Pharma SA
PA:OSE |
$69.88 Million | €59.77 Million | France | €2.67 | -1.77% | -12.82% | 3.24 Million |
| 747 |
Pliant Therapeutics Inc
NASDAQ:PLRX |
$69.35 Million | $69.35 Million | USA | $1.12 | -2.61% | -3.45% | 10.96 Million |
| 748 |
Recce Pharmaceuticals Ltd
AU:RCE |
$69.23 Million | AU$97.85 Million | Australia | AU$0.32 | -8.57% | -11.11% | 1.94 Million |
| 749 |
Abionyx Pharma SA
PA:ABNX |
$68.88 Million | €58.92 Million | France | €1.67 | -1.18% | -10.22% | 4.33 Million |
| 750 |
Lytix Biopharma AS
OL:LYTIX |
$68.78 Million | Nkr653.65 Million | Norway | Nkr8.50 | +1.43% | +5.99% | 890.73K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries